- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02796586
Group Versus Individual Contraceptive Counseling for Resettled African Refugee Women
Salt Lake Refugee Women's Health Project-Group Versus Individual Contraceptive Counseling for Resettled African Refugee Women
Study Overview
Detailed Description
Thousands of women refugees arrive in the United States each year, yet there is very little known about reproductive health and family planning needs of these women after resettlement.
This randomized controlled pilot study, in a population of resettled African refugee women, will evaluate differences between group and individual contraceptive counseling on the decision to use contraception, satisfaction with counseling method, and modern family planning knowledge.
Participants will arrive to clinic during an assigned "intervention day." An intake and exit survey will be performed before and after their counseling session. Demographics, attitudes towards contraception, and knowledge regarding contraceptive methods will be assessed via questionnaire. Participants will be randomized to either group or individual contraceptive counseling. After each session, participants will have the option to privately choose a reversible method of contraception free of charge.
Telephone survey follow-up with participants will occur every three months for one year. Follow-up surveys will include questions regarding method continuation, method satisfaction and and modern contraceptive knowledge.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Utah
-
Salt Lake City, Utah, United States, 84132
- University of Utah Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Resettled refugee
- Ability to speak and comprehend conversational Swahili, French or Lingala
- Interest in contraceptive counseling
- Willing to adhere to study protocols including randomization and follow-up
- Cellular phone access
Exclusion Criteria:
- Male
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Individual Contraceptive Counseling
Performed by a medical provider and planned to simulate a typical clinic visit addressing contraception.
|
Participants will be randomly assigned to group versus individual contraceptive counseling
|
Experimental: Group Contraceptive Counseling
Performed by a bicultural study staff member who speaks the primary languages of participants and had been formally trained in contraception counseling.
|
Participants will be randomly assigned to group versus individual contraceptive counseling
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Knowledge Acquisition assessed via number of correct questions on modified FogZone questionnaire
Time Frame: Day of intervention (Study Day 1)
|
Evaluate knowledge acquisition by comparing results on pre and post test of modern contraceptive knowledge.
Contraceptive knowledge will be assessed using a modified version of the FogZone questionnaire
|
Day of intervention (Study Day 1)
|
Contraceptive uptake
Time Frame: Day of intervention (Study day 1)
|
Evaluate contraceptive uptake via query of method choice after counseling
|
Day of intervention (Study day 1)
|
Service Satisfaction via questionnaire
Time Frame: Day of intervention (Study day 1)
|
Evaluate satisfaction with service and type of counseling received using questionnaire
|
Day of intervention (Study day 1)
|
Service satisfaction via Likert Scale
Time Frame: Day of intervention (Study day 1)
|
Evaluate satisfaction with service and type of counseling received using questionnaire
|
Day of intervention (Study day 1)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Method Continuation
Time Frame: 3, 6, 9 and 12 months post-intervention
|
Evaluate method continuation via telephone survey
|
3, 6, 9 and 12 months post-intervention
|
Knowledge Retention assessed via modified FogZone questionnaire
Time Frame: 3, 6, 9 and 12 months post-intervention
|
Evaluate knowledge retention by repeating knowledge questionnaire and comparing baseline and interval results.
|
3, 6, 9 and 12 months post-intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Par Royer, MD MSCI, University of Utah
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 00080655
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Contraception
-
Virginia Commonwealth UniversityCompletedPregnancy Related | Contraception | Contraception Behavior | Contraception Use
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception | Contraception
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception | Contraception
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
Medical University of South CarolinaSociety of Family PlanningCompletedContraception | Contraception BehaviorUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedFemale Contraception | ContraceptionUnited States, Israel
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception | Contraception
-
Montefiore Medical CenterSociety of Family PlanningCompletedContraception | Breastfeeding | Postpartum ContraceptionUnited States
Clinical Trials on Counseling
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedMalignant NeoplasmUnited States
-
Texas Christian UniversityTerminated
-
Lata Medical Research Foundation, NagpurUnknownMalnutrition in Pregnancy | Other Disorders of Breast and Lactation Associated With ChildbirthIndia
-
Port Said UniversityMansoura University; Prince Sattam Bin Abdulaziz UniversityRecruitingFertility IssuesEgypt
-
Loyola UniversityCompletedUterine Leiomyoma
-
Saglik Bilimleri Universitesi Gulhane Tip FakultesiCompletedAnxiety | Knowledge, Attitudes, Practice | Decision Making | Chromosome AbnormalityTurkey
-
University of PadovaFondazione Guido Berlucchi; Veneto Institute of Oncology I.O.V.-I.R.C.C.S.Terminated
-
International Centre for Diarrhoeal Disease Research...Completed
-
UKK InstituteFinnish Institute of Occupational Health; Academy of Finland; Vitalmed Research...CompletedEffects of Weight Reduction on Sleep and Alertness in Long-distance Truck and Bus Drivers (SF-Truck)Abdominal ObesityFinland
-
Federal University of São PauloUnknownPain | Myofascial Pain | Facial Pain | Therapeutic Exercise | Temporomandibular Disorder SyndromeBrazil